Therapeutic area

Skin and subcutaneous tissue disorders – page 68

843 clinical trials
269 recruiting
353 conditions
25 countries

Clinical trials in Skin and subcutaneous tissue disorders

843 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

843 clinical trials

Psoriasis

Not recruiting

InvestigationalNo placebo

Study of Risankizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

InvestigationalNo placebo

Germany

Participants:0–17 years
Substances:Risankizumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Netherton's syndrome

Not recruiting

Registered drug

Study on the Safety of DS-2325a for Patients with Netherton Syndrome

Registered drug

France

Participants:18–64 years
Substances:Ds-2325A
Sponsor:Daiichi Sankyo Inc.

Contact Research Centre

Actinic cheilitis

Not recruiting

Registered drugNo placebo

Study on the Tolerability and Effectiveness of Tirbanibulin for Patients with Actinic Cheilitis

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Tirbanibulin
Sponsor:Technische Universitaet Dresden

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Investigational

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Upadacitinib
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Thermal burn

Not recruiting

Registered drug

Study on the Effects of High-Dose Vitamin C in Patients with Severe Burns

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Ascorbic Acid
Sponsor:Queen's University

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Sar442970
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Psoriasis

Not recruiting

Investigational

Study on the Effectiveness and Safety of DC-806 for Adults with Moderate to Severe Plaque Psoriasis

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Dc-806
Sponsor:DICE Therapeutics Inc.

Contact Research Centre

Neurodermatitis

Not recruiting

Investigational

Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Ruxolitinib
Sponsor:Incyte Corp.

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drugNo placebo

Study on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis

Registered drugNo placebo

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Chronic cutaneous lupus erythematosus+2

Not recruiting

Investigational

Study on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus

Investigational

France

Participants:18–64 years · 65+ years
Substances:Deucravacitinib
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Squamous cell carcinoma of head and neck+1

Not recruiting

Registered drugNo placebo

Study of IO102-IO103 and Pembrolizumab for Patients with Resectable Melanoma and Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Io103 Acetate
Sponsor:Io Biotech ApS

Contact Research Centre

Substances studied in this area

The therapies tested most often in Skin and subcutaneous tissue disorders trials.

Pembrolizumab57 clinical trials Nivolumab33 clinical trials Sodium Chloride22 clinical trials Deucravacitinib19 clinical trials Cemiplimab18 clinical trials Upadacitinib17 clinical trials Ipilimumab15 clinical trials Rituximab13 clinical trials Cyclophosphamide12 clinical trials

Skin and subcutaneous tissue disorders – page 68

Conditions in this area

Clinical trials in Skin and subcutaneous tissue disorders

843 clinical trials

Psoriasis

Study of Risankizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

Netherton's syndrome

Study on the Safety of DS-2325a for Patients with Netherton Syndrome

Actinic cheilitis

Study on the Tolerability and Effectiveness of Tirbanibulin for Patients with Actinic Cheilitis

Dermatitis atopic

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Malignant melanoma

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Thermal burn

Study on the Effects of High-Dose Vitamin C in Patients with Severe Burns

Hidradenitis

Study on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa

Psoriasis

Study on the Effectiveness and Safety of DC-806 for Adults with Moderate to Severe Plaque Psoriasis

Neurodermatitis

Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

Dermatitis atopic

Study on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis

Chronic cutaneous lupus erythematosus+2

Study on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus

Squamous cell carcinoma of head and neck+1

Study of IO102-IO103 and Pembrolizumab for Patients with Resectable Melanoma and Head and Neck Squamous Cell Carcinoma

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.